Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes

Tariq Kewan, Waled Bahaj, Arda Durmaz, Mai Aly, Olisaemeka D. Ogbue, Hetty E. Carraway, Mikkael A. Sekeres, Valeria Visconte, Carmelo Gurnari, Jaroslaw P. Maciejewski

Blood (2023) 141 (14): 1768–1772.

https://doi.org/10.1182/blood.2022018896

Published: 2023

Includes: Supplemental data

Journal Articles

Immune Checkpoint Molecules Regulate Paroxysmal Nocturnal Hemoglobinuria Clonal Evolution

Naomi Kawashima, BEN Ponvilawan, Pat Rayman, Jennifer Powers, Fauzia Ullah, Yasuo Kubota, Mai Aly, Li Lily Wang, Simona Pagliuca, Valeria Visconte, C. Marcela Diaz-Montero, Jaroslaw P. Maciejewski, Carmelo Gurnari

Blood (2022) 140 (Supplement 1): 5790–5791.

https://doi.org/10.1182/blood-2022-164937

Published: 2022

Journal Articles

A Clinically Practicable Approach to Predict TP53 Allelic Configurations in Myeloid Neoplasia

Blood (2022) 140 (Supplement 1): 2075–2077.

https://doi.org/10.1182/blood-2022-162913

Published: 2022

Journal Articles

Dead and Deah-Box Helicases Other Than DDX41 Are Mutated in Myeloid Neoplasia

Carmelo Gurnari, Arda Durmaz, Yasuo Kubota, Mai Aly, Olisaemeka Ogbue, Fauzia Ullah, Danai Dima, Hussein Awada, Naomi Kawashima, Thomas LaFramboise, Richard A Padgett, Torsten Haferlach, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2022) 140 (Supplement 1): 9747–9748.

https://doi.org/10.1182/blood-2022-160439

Published: 2022

Journal Articles

Clinico-Molecular Risk Factors and Management of Thrombosis in a Large Real-Life Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria in the New Era of Anti-Complement Inhibitors and Doacs

Carmelo Gurnari, Hussein Awada, Mai Aly, Danai Dima, Fauzia Ullah, Naomi Kawashima, Yasuo Kubota, Ceylan Colak, Valeria Visconte, Simona Pagliuca, Bhumika J. Patel, Taha Bat, Jaroslaw P. Maciejewski

Blood (2022) 140 (Supplement 1): 8513–8514.

https://doi.org/10.1182/blood-2022-160479

Published: 2022

Journal Articles

Molecular and Clinical PHF6 Mutant Myeloid Neoplasia Provides Clues As to Their Pathogenesis and Therapeutic Targeting

Yasuo Kubota, Laila Terkawi, Carmelo Gurnari, Juraj Bodo, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, BEN Ponvilawan, Tariq Kewan, Waled Bahaj, Valeria Visconte, Heesun J. Rogers, Torsten Haferlach, Jaroslaw P. Maciejewski

Blood (2022) 140 (Supplement 1): 8707–8708.

https://doi.org/10.1182/blood-2022-169214

Published: 2022

Journal Articles

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndrome

Tariq Kewan, Waled Bahaj, Mai Aly, Arda Durmaz, Olisaemeka Ogbue, Hetty E. Carraway, Abhay Singh Singh, Suresh Kumar Balasubramanian, Mikkael A. Sekeres, Valeria Visconte, Carmelo Gurnari, Jaroslaw P. Maciejewski

Blood (2022) 140 (Supplement 1): 6942–6944.

https://doi.org/10.1182/blood-2022-163845

Published: 2022

Journal Articles

Role of MBD4 Mutation in Neoplastic Evolution of Acute Myeloid Leukemia

Naomi Kawashima, Dongxu Jiang, Divya Jyoti Singh, Dale Grabowski, Carmelo Gurnari, Yasuo Kubota, Mai Aly, Valeria Visconte, Brittany L Griffin, Torsten Haferlach, Jaroslaw P. Maciejewski, Babal K. Jha

Blood (2022) 140 (Supplement 1): 8783–8784.

https://doi.org/10.1182/blood-2022-163694

Published: 2022

Journal Articles

Predicting the Outcome in Egyptian Patients with Severe Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Matched Sibling Donors

Mai Aly, MD BSc, MS, Hassan Awada, MD, Douaa Sayed, MD, Esam ElBeih, MD, Raafat Abdel El Fattah, MD, Refat Fathy Abdel-Aal Naseer, MD, Reem Alagooz, MD, Rania Hafez, MD, Almetwaly M. Sultan, MD, Nahla El-Sharkawy, MD, Valeria Visconte, PhD, Reda Z. Mahfouz, MD PhD

Blood (2019) 134 (Supplement_1): 5652.

https://doi.org/10.1182/blood-2019-132183

Published: 2019

Journal Articles

Biallelic TET2 Inactivation in Myeloid Neoplasia: From Clonal Hierarchy to Clinical Phenotypes

Blood (2018) 132 (Supplement 1): 1805.

https://doi.org/10.1182/blood-2018-99-115154

Published: 2018

Journal Articles

Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes

Blood (2018) 132 (21): 2309–2313.

https://doi.org/10.1182/blood-2017-05-787390

Published: 2018

Includes: Supplemental data

Journal Articles

PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms

Reem Elagooz, MS, MD, Mai Aly, MD MS, Cassandra M. Hirsch, BS, Bartlomiej P. Przychodzen, MSc, Teodora Kuzmanovic, BA, Tomas Radivoyevitch, Valeria Visconte, PhD, Sudipto Mukherjee, MD PhD MPH, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Jaroslaw P. Maciejewski, PhD MD FACP, Yasunobu Nagata, MD PhD

Blood (2017) 130 (Supplement 1): 4233.

https://doi.org/10.1182/blood.V130.Suppl_1.4233.4233

Published: 2017

Journal Articles

Extent and Clinical Implications of Subclonal Diversity in Paroxysmal Nocturnal Hemoglobinuria

Mohammad Fahad B Asad, MD MBBS, Abhinav Goyal, MD, Hassan Awada, MD, Mai Aly, Cassandra Hirsch, Michael J. Clemente, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Sudipto Mukherjee, MD PhD MPH, Yasunobu Nagata, MD PhD, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 779.

https://doi.org/10.1182/blood.V130.Suppl_1.779.779

Published: 2017

Journal Articles

How Somatic Mutations Carve Morphologic Imprint in MDS?

Abhinav Goyal, MD, Mohammad Fahad B Asad, MD MBBS, Hassan Awada, MD, Mai Aly, MD, Cassandra M. Hirsch, BS, Bartlomiej P. Przychodzen, MSc, Tomas Radivoyevitch, PhD, Aziz Nazha, MD, Sudipto Mukherjee, MD PhD MPH, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, PhD MD FACP, Yasunobu Nagata, MD PhD

Blood (2017) 130 (Supplement 1): 2949.

https://doi.org/10.1182/blood.V130.Suppl_1.2949.2949

Published: 2017

Journal Articles

Non-Random Interactions between Founder and Subclonal Mutations Shape the Clinical and Morphological Features of MDS

Blood (2017) 130 (Supplement 1): 583.

https://doi.org/10.1182/blood.V130.Suppl_1.583.583

Published: 2017

Journal Articles

Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms

Mai Aly, MD, Zubaidah M Ramdzan', PhD, Yasunobu Nagata, MD PhD, Suresh K. Balasubramanian, MD, Naoko Hosono, MD,PhD, Hideki Makishima, MD,PhD,FACP., Valeria Visconte, PhD, Bartlomiej P. Przychodzen, MSc, Cassandra M. Hirsch, BS, Mikkael A. Sekeres, MD MS, Alain Nepveu", PhD, Jaroslaw Maciejewski", MD,PhD,FACP.

Blood (2017) 130 (Supplement 1): 120.

https://doi.org/10.1182/blood.V130.Suppl_1.120.120

Published: 2017

Journal Articles

Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms

Mai Aly, Naoko Hosono, MD,PhD, Przychodzen Bartlomiej, Hideki Makishima, MD PhD FACP., Nagata Yasunobu, MDPhD, Cassandra M. Hirsch, BSc, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2016) 128 (22): 3156.

https://doi.org/10.1182/blood.V128.22.3156.3156

Published: 2016

Journal Articles

BCOR and BCORL1 mutations in Myelodysplastic Syndromes (MDS): Clonal Architecture and Impact on Outcomes

Nour Abuhadra, MD, Karam Al-Issa, MD, Aaron T. Gerds, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H., Bhumika Patel, MD, Michael J. Clemente, M.S., Vera Adema, PhD, Cassandra M. Hirsch, BSc, Anjali S. Advani, MD, Mai Aly, Przychodzen P Bartlomiej, Hetty E. Carraway, MD, Jaroslaw P Maciejewski, MD PhD FACP, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD

Blood (2016) 128 (22): 4293.

https://doi.org/10.1182/blood.V128.22.4293.4293

Published: 2016

Journal Articles

TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS)

Karam Al-Issa, MD, Mikkael A. Sekeres, MD MS, Alek d Nielsen, B.S., Babal Jha, PhD, Bartlomiej P Przychodzen, MSc, Mai Aly, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Bhumika Patel, MD, Michael J. Clemente, M.S., Sudipto Mukherjee, MD, PhD, M.P.H., Aaron T. Gerds, MD MS, Jaroslaw P Maciejewski, MD PhD FACP, Aziz Nazha, MD

Blood (2016) 128 (22): 4336.

https://doi.org/10.1182/blood.V128.22.4336.4336

Published: 2016

NARROW

Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes

Immune Checkpoint Molecules Regulate Paroxysmal Nocturnal Hemoglobinuria Clonal Evolution

A Clinically Practicable Approach to Predict TP53 Allelic Configurations in Myeloid Neoplasia

Dead and Deah-Box Helicases Other Than DDX41 Are Mutated in Myeloid Neoplasia

Clinico-Molecular Risk Factors and Management of Thrombosis in a Large Real-Life Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria in the New Era of Anti-Complement Inhibitors and Doacs

Molecular and Clinical PHF6 Mutant Myeloid Neoplasia Provides Clues As to Their Pathogenesis and Therapeutic Targeting

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndrome

Role of MBD4 Mutation in Neoplastic Evolution of Acute Myeloid Leukemia

Predicting the Outcome in Egyptian Patients with Severe Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Matched Sibling Donors

Biallelic TET2 Inactivation in Myeloid Neoplasia: From Clonal Hierarchy to Clinical Phenotypes

Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes

PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms

Extent and Clinical Implications of Subclonal Diversity in Paroxysmal Nocturnal Hemoglobinuria

How Somatic Mutations Carve Morphologic Imprint in MDS?

Non-Random Interactions between Founder and Subclonal Mutations Shape the Clinical and Morphological Features of MDS

Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms

Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms

BCOR and BCORL1 mutations in Myelodysplastic Syndromes (MDS): Clonal Architecture and Impact on Outcomes

TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only